Medidata Risk Management – Enabling Patient Safety And Data Integrity

Medidata Risk Management supports the growing complexity of clinical trials by enabling proactive study design that includes defining and monitoring Quality Tolerance Limits (QTLs). Medidata supports you by designing quality into your clinical trials rather than a reactionary approach of monitoring quality in your trials.

By adopting a risk-based approach to clinical studies, your trial teams can identify, and report risks associated with critical data and processes that enable you to answer key questions and support sound decision-making while protecting study subjects.

Now you can develop cross-functional quality management into protocol design as well as study operations and execution.

Product Benefits

By adopting a risk-based approach to clinical studies, your trial teams can identify risks associated with critical data and processes that need to be monitored for Good Clinical Practice (GCP). Now Medidata Risk Management can help you achieve:

• Proactive Risk Management
• Greater Visibility
• Risk Reporting
• Communication is Key